Literature DB >> 1912407

Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.

A S Levey1, J J Gassman, P M Hall, W G Walker.   

Abstract

Many clinical studies of the effects of low-protein and low-phosphorus diets on the course of chronic renal disease have used the rate of decline in renal function to assess the rate of progression. In this report, data from the feasibility phase of the Modification of Diet in Renal Disease Study were used to analyze methods used in other studies. The focus is particularly on the effects of duration of follow-up and of regression to the mean. The findings are summarized as follows. (1) During the mean follow-up period of 14.1 months, rates of decline in glomerular filtration rate, creatinine clearance, and the reciprocal of the serum creatinine concentration were highly variable among individuals, and mean rates of decline were slow. (2) Precision of estimates of individual rates of decline in renal function were relatively low and improved with increasing duration of follow-up. (3) Correlations between rates of decline in creatinine clearance and the reciprocal of the serum creatinine concentration with glomerular filtration rate in individuals were significant but weak and became stronger with increasing duration of follow-up. (4) After entry into the study, mean rate of decline in the reciprocal of the serum creatinine concentration became less negative. The change predicted simply from regression to the mean was 68.4% of the observed change.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912407     DOI: 10.1681/ASN.V191087

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

1.  Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.

Authors:  E R Mathiesen; E Hommel; H P Hansen; U M Smidt; H H Parving
Journal:  BMJ       Date:  1999-07-03

2.  Effects of statins on the kidneys in patients with type 2 diabetes.

Authors:  Ko Hanai; Tetsuya Babazono; Yasuko Uchigata
Journal:  Clin Exp Nephrol       Date:  2016-09-15       Impact factor: 2.801

3.  The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach.

Authors:  Elke S Schaeffner; Markus van der Giet; Jens Gaedeke; Markus Tölle; Natalie Ebert; Martin K Kuhlmann; Peter Martus
Journal:  Eur J Epidemiol       Date:  2010-01-22       Impact factor: 8.082

Review 4.  At risk nephrons and the decline in renal function in response to treatment of hypertension.

Authors:  W G Walker; C Ford
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

Review 5.  Renal function trajectory over time and adverse clinical outcomes.

Authors:  Badrul Munir Sohel; Nahid Rumana; Masaki Ohsawa; Tanvir Chowdhury Turin; Martina Ann Kelly; Mohammad Al Mamun
Journal:  Clin Exp Nephrol       Date:  2016-01-04       Impact factor: 2.801

6.  Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.

Authors:  H H Parving; P Jacobsen; L Tarnow; P Rossing; L Lecerf; O Poirier; F Cambien
Journal:  BMJ       Date:  1996-09-07

Review 7.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

8.  Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria.

Authors:  T Babazono; K Hanai; K Suzuki; Y Kiuchi; A Inoue; M Tanaka; N Tanaka; M Hase; A Ishii; Y Iwamoto
Journal:  Diabetologia       Date:  2006-04-13       Impact factor: 10.122

9.  Association between CNDP1 genotype and diabetic nephropathy is sex specific.

Authors:  Antien L Mooyaart; Ana Zutinic; Stephan J L Bakker; Diana C Grootendorst; Nanne Kleefstra; Irene G M van Valkengoed; Stefan Böhringer; Henk J G Bilo; Friedo W Dekker; Jan Anthonie Bruijn; Gerjan Navis; Bart Janssen; Hans J Baelde; Emile De Heer
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

10.  Monitoring kidney function in diabetic nephropathy.

Authors:  P Rossing; A S Astrup; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.